Herpes Zoster, Hepatitis C, and Tuberculosis Risk with Apremilast Compared to Biologics, DMARDs and Corticosteroids to Treat Psoriasis and Psoriatic Arthritis.

Katrina Wilcox HagbergRebecca PerssonCatherine Vasilakis-ScaramozzaSteve NiemcrykMichael PengMaria ParisAnders LindholmSusan S Jick

Published in: Clinical epidemiology (2020)

Rates of herpes zoster varied by treatment: highest among those who received polytherapy, lowest in users of apremilast only. IRs for HepC and TB were low for all exposures.

Keyphrases

mycobacterium tuberculosis
air pollution
emergency department
pulmonary tuberculosis
combination therapy
rheumatoid arthritis
systemic lupus erythematosus
atopic dermatitis
antiretroviral therapy